openPR Logo
Press release

Roxithromycin Market History Key Manufacturers are Hetero Healthcare Ltd., Finecure Pharmaceuticals Ltd., Zhejiang Zhenyuan Pharmaceutical Co Ltd, Johnson & Johnson Private Limited, Hygeia Laboratories Inc, Bayer AG

04-08-2019 12:16 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Roxithromycin

Roxithromycin

Increasing research for new applications of roxithromycin is expected to propel growth of the roxithromycin market during the forecast period. For instance, according to a research by Otago University, New Zealand in July 2018, roxithromycin can be effective in treating myeloma, a cancer of plasma cells that usually arises in the bone marrow and is mainly associated with depletion of hemoglobin levels. The drug aids in increasing hemoglobin levels, which strongly suggests that the amount of myeloma in bone marrow has reduced. However, the drug is still under research to confirm its use in treating myeloma.

Get a Request Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2257

North America is expected to hold dominant position in the global roxithromycin market during the forecast period. This is owing to increasing government initiatives to prevent antimicrobial resistance and growing awareness for proper use of antibiotics. For instance in March 2015, Health Canada released Federal Action Plan with rules to reduce the risk of antimicrobial resistance in Canada, which includes infection prevention and control, research and innovation in developing antibiotics, and appropriate antimicrobial use for health professionals and the public of Canada.

Asia Pacific is expected to witness significant growth in the global roxithromycin market during the forecast period. This is owing to high infectious disease burden, unregulated sales of antibiotics and poor public health infrastructure, which are leading to increasing use of antibiotics in economies such as India. For instance, according to a report published in the journal The Lancet Infectious Diseases February 2017, Low-Income and Middle-Income Countries (LMICs) of Asia Pacific such as Nepal, Pakistan, India, and Bangladesh witness significant demand for roxithromycin, owing to less stringent policies and easy availability of antibiotics over the counter.

Drug recalls due to failures in meeting quality standards is expected to hinder growth of the market. For instance, in July 2016, Ministry of Health, Vietnam recalled Rom-150 tablets (Roxithromycin 150mg) manufactured by Zee Laboratories and imported by Codupha Central Pharmaceutical JSC in Vietnam. The decision to recall these drugs was based on tests performed by the National Institute of Drug Quality Control.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/2257

Key players operating in the global roxithromycin market include, Hetero Healthcare Ltd., Finecure Pharmaceuticals Ltd., Zhejiang Zhenyuan Pharmaceutical Co Ltd, Johnson & Johnson Private Limited, Hygeia Laboratories Inc, Bayer AG, Allergan plc., Galderma S.A, Valeant Pharmaceutical International, and Stiefel Laboratories

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Roxithromycin Market History Key Manufacturers are Hetero Healthcare Ltd., Finecure Pharmaceuticals Ltd., Zhejiang Zhenyuan Pharmaceutical Co Ltd, Johnson & Johnson Private Limited, Hygeia Laboratories Inc, Bayer AG here

News-ID: 1692690 • Views: 305

More Releases from Coherent Market Insights

Alzheimer’s Drugs Market Pegged For Robust Expansion During 2018 – 2026
Coherent Market Insights Market Reports offers 2019 Depth Insights report on Global Alzheimer’s Drugs market that evaluates industry growth trends, through historical data and estimates future prospects based on comprehensive research. The report also identifies the factors driving this market, various restraints and opportunities impacting it along with the adoption trends for the period 2018-2026. The Alzheimer’s Drugs market research report displays the latest industry insights with future trends and analysis
Oral Biologics Market Aims to Expand at Double-Digit Growth Rate
In February 2019, researchers at Massachusetts Institute of Technology (MIT) developed a drug capsule with the potential to deliver an oral insulin named SOMA capsule, thereby replacing (or eliminating) the need to administer insulin via injections multiple times a day for patients with type 1 diabetes. The researchers stated that the drugs is currently under preclinical studies and is expected to enter clinical trials by 2022. The research was funded by
Drive Growth of the Intraocular Lens Market Research Report 2019 Explain - How l …
According to the International Diabetes Foundation (IDF) 2017 statistics, the number of people with diabetes aged between 20 to 79 years are increasing, globally. Among which, Africa (156%) is accounted to register the highest diabetic population, followed by Middle East (110%), South East Asia (84%), Latin and Central America(62%), North America (35%), Europe (16%) and Western Pacific (15%). Moreover, cataract is major cause of blindness, which is projected to fuel
𝗣𝗲𝗻𝗲𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗠 …
Penetration testing is also known as pen testing. It is a simulated process used to test a computer system, application or a network to check for security weaknesses, which could be easily capitalized on by hacker. They are designed in such way that they will be useful in security assessments and security testing. Penetration Testing Market shows a detailed analysis of various key market factors such as market size, market

All 5 Releases


More Releases for Roxithromycin

Roxithromycin Market Intelligence by Top Key Players Hetero Healthcare Ltd., Fin …
Increasing research for new applications of roxithromycin is expected to propel growth of the roxithromycin market during the forecast period. For instance, according to a research by Otago University, New Zealand in July 2018, roxithromycin can be effective in treating myeloma, a cancer of plasma cells that usually arises in the bone marrow and is mainly associated with depletion of hemoglobin levels. The drug aids in increasing hemoglobin levels, which
Roxithromycin Market Is Anticipated To Be High Valued By The End Of 2026 Estimat …
Roxithromycin, also known as arrow-roxithromycin, is a semi-synthetic macrolide antibiotic, which prevents bacterial growth by interfering with protein synthesis. The drug is indicated to treat certain types of bacterial infections such as pharyngitis, sinusitis, bronchitis and pneumonia, urinary and soft tissue infections, and otitis media. Roxithromycin Market– Driver Increasing research for new applications of roxithromycin is expected to propel growth of the roxithromycin market during the forecast period. For instance, according to
Roxithromycin Market Revenue Opportunies By Top Players Hetero Healthcare Ltd., …
Increasing research for new applications of roxithromycin is expected to propel growth of the roxithromycin market during the forecast period. For instance, according to a research by Otago University, New Zealand in July 2018, roxithromycin can be effective in treating myeloma, a cancer of plasma cells that usually arises in the bone marrow and is mainly associated with depletion of hemoglobin levels. The drug aids in increasing hemoglobin levels, which
Global and Chinese Roxithromycin Industry, 2018 Market Growth,Applications ,Stat …
Research Beam has added a report on “Global and Chinese Roxithromycin Industry, 2018 Market Research Report” Roxithromycin Industry is provided in the report based on product scope and market status & outlook. The market is segmented on the basis of type, end-users/application, and geography. The report provides information about the production, price, revenue, market share, and growth rate of each type. Geographically, the market has been analyzed across North America, Europe,
Global Roxithromycin Market 2017 : Business Rising Awareness, Financial Plan to …
Qyresearchreports include new market research report Global Roxithromycin Sales Market Report 2017 to its huge collection of research reports. The exhaustive report here gathers diverse viewpoints having an area with the overall Roxithromycin marketplace which verbalizes the winning-day statistics and future exposures on the subject of the dynamic forces at play. The prime reason for the examination report is to provide the endorser with an expansive format and make to be
Global and Europe Antibiotics Market - Analysis and Outlook to 2022
This report presents a comprehensive overview of the Antibiotics market in Europe. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. This report provides a detailed analysis of the market, its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Antibiotics industry. This report focus Global and Europe market, it